cryptocurrency is based on Top Knowledge

South Korea's Seoul Composite Index rose to 1%.Japan's semiconductor sector rose collectively, with ADVANTEST up nearly 5%, DISCO up over 2% and Renesas Electronics up over 1%.Market News: South Korean President Yin Xiyue may release a recorded public speech.

Zhong Xuegao's subsidiary was forced to execute 16.62 million yuan. According to the legal litigation information, recently, Zhongmao (Shanghai) Food Technology Co., Ltd. added a piece of information about the person to be executed, with the execution target of 16.62 million yuan. The enforcement court is the Yangpu District People's Court in Shanghai. Zhongmao (Shanghai) Food Technology Co., Ltd. was established in June 2020. The legal representative is Wang Keqin, with a registered capital of RMB 10 million, and it is wholly owned by Zhong Xuegao Food (Shanghai) Co., Ltd. Tianyan risk information shows that the company has more than 20 pieces of information about executed persons, and the total amount of execution exceeds 31.62 million yuan. In addition, there are also a number of consumption restriction orders, untrustworthy executed persons (Lao Lai) and final case information.Market News: South Korean President Yin Xiyue may release a recorded public speech.Offshore RMB and Australian dollar rose slightly. Affected by the news, USD/offshore RMB fell 0.1% to 7.2696. AUD/USD rose 0.2% to 0.6381. A foreign exchange trader in Asia said that the small leveraged account that shorted AUD/USD on Wednesday also closed its position. NZD/USD rose 0.1% to 0.5792.

Japanese and Korean stock markets opened higher, with the Nikkei 225 index rising 1.21% to 39,849.97. South Korea's KOSPI index rose 0.6% to 2,456.63.Australia's unemployment rate in November was 3.93%, which is estimated to be 4.2%.Citic Jiantou: We are optimistic about the investment opportunities in the pharmaceutical industry in 2025, focusing on the opportunities of new increase and industry integration. Citic Jiantou Securities reported on December 11th that looking forward to 2025, the reform policy in the pharmaceutical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations on the whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.